Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | +2 |
| Ticker | PNV |
| Latest Price | 1.22 AUD as of close on 04-Jul-2025 |
| 3 Month price range | 0.97 to 1.67 AUD |
| Market Capitalisation | 839.37Mn AUD |
| Country | Australia |
| Region | Asia |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal scaffold for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia. See More ... |
| Company URL | https://polynovo.com |
| See Darwins Full Analysis for Polynovo Ltd |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Polynovo Ltd. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -6 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +1 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | +7 |
There are 3 live alerts for Polynovo Ltd.
There are 12 peers of Polynovo Ltd.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Argenica Therapeutics Ltd (AGN) | Biotechnology | -2.0 | +22 |
| Arovella Therapeutics Ltd (ALA) | Biotechnology | +19.2 | +2 |
| CSL Ltd (CSL) | Biotechnology | -2.1 | +19 |
| Clinuvel Pharmaceuticals Ltd (CUV) | Biotechnology | -1.9 | +7 |
| Imugene Ltd (IMU) | Biotechnology | -23.7 | -9 |
| Mesoblast Ltd (MSB) | Biotechnology | -7.9 | -10 |
| Opthea Ltd (OPT) | Biotechnology | 0 | -12 |
| PYC Therapeutics Ltd (PYC) | Biotechnology | +9.1 | +24 |
| Paradigm Biopharmaceuticals Ltd (PAR) | Biotechnology | +49.2 | +18 |
| Race Oncology Ltd (RAC) | Biotechnology | -0.4 | -9 |
| Telix Pharmaceuticals Ltd (TLX) | Biotechnology | -11.9 | +7 |
| Tissue Repair Ltd (TRP) | Biotechnology | +16.2 | -10 |
To see complete information on Polynovo Ltd or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |